NAMA
IONS icon

Nikko Asset Management Americas’s Ionis Pharmaceuticals IONS Stock Holding History

Nikko Asset Management Americas’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.78M Sell
47,656
-34,040
-42% -$2.56M 0.05% 114
2026
Q1 		$6.13M Sell
81,696
-11,875
-13% -$937K 0.09% 103
2025
Q4 		$7.4M Sell
93,571
-21,021
-18% -$1.58M 0.09% 97
2025
Q3 		$7.49M Sell
114,592
-25,147
-18% -$1.23M 0.07% 97
2025
Q2 		$5.52M Sell
139,739
-2,694
-2% -$88.2K 0.06% 100
2025
Q1 		$4.3M Sell
142,433
-14,224
-9% -$466K 0.06% 101
2024
Q4 		$5.47M Sell
156,657
-39,457
-20% -$1.47M 0.06% 94
2024
Q3 		$7.86M Sell
196,114
-3,117
-2% -$145K 0.09% 90
2024
Q2 		$9.5M Sell
199,231
-21,030
-10% -$863K 0.11% 84
2024
Q1 		$9.55M Sell
220,261
-32,198
-13% -$1.53M 0.09% 86
2023
Q4 		$12.8M Sell
252,459
-40,014
-14% -$1.92M 0.12% 82
2023
Q3 		$13.3M Sell
292,473
-3,659
-1% -$151K 0.16% 75
2023
Q2 		$12.1M Sell
296,132
-1,337
-0.4% -$51.4K 0.13% 80
2023
Q1 		$9.83M Sell
297,469
-39,263
-12% -$1.47M 0.11% 87
2022
Q4 		$12.7M Sell
336,732
-100,444
-23% -$4.22M 0.18% 69
2022
Q3 		$16M Sell
437,176
-30,940
-7% -$1.3M 0.2% 72
2022
Q2 		$15.4M Sell
468,116
-131,500
-22% -$4.96M 0.19% 73
2022
Q1 		$21.5M Sell
599,616
-6,286
-1% -$206K 0.16% 79
2021
Q4 		$17.9M Sell
605,902
-69,399
-10% -$2.18M 0.09% 94
2021
Q3 		$22.6M Buy
675,301
+166,927
+33% +$6.29M 0.1% 94
2021
Q2 		$20.4M Buy
508,374
+10,118
+2% +$396K 0.08% 99
2021
Q1 		$22.4M Buy
498,256
+175,088
+54% +$9.76M 0.11% 100
2020
Q4 		$18.3M Buy
323,168
+95,501
+42% +$4.76M 0.1% 103
2020
Q3 		$10.7M Sell
227,667
-19,252
-8% -$1.07M 0.1% 109
2020
Q2 		$14.3M Sell
246,919
-134,193
-35% -$7.47M 0.19% 73
2020
Q1 		$18M Sell
381,112
-43,571
-10% -$2.43M 0.33% 68
2019
Q4 		$25.7M Buy
424,683
+60,592
+17% +$3.61M 0.4% 63
2019
Q3 		$21.8M Buy
364,091
+56,089
+18% +$3.66M 0.39% 59
2019
Q2 		$19.8M Buy
308,002
+128,469
+72% +$9.08M 0.39% 58
2019
Q1 		$14.6M Buy
+179,533
New +$11.6M 0.38% 56

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Nikko Asset Management Americas's IONS Position: Q2 2026 in Review

Nikko Asset Management Americas reduced its Ionis Pharmaceuticals (IONS) stake by 42% in Q2 2026, selling an estimated $2.56M and leaving 47,656 shares worth $3.78M. The position accounts for 0.05% of the portfolio, ranked #114.

Nikko Asset Management Americas first reported a position in IONS in Q1 2019 and has held it in 30 quarters since. The position peaked at $25.7M in Q4 2019. 513 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Nikko Asset Management Americas held 47,656 shares of Ionis Pharmaceuticals worth $3.78M as of Q2 2026.
  • Nikko Asset Management Americas sold 34,040 Ionis Pharmaceuticals shares in Q2 2026, an estimated $2.56M.
  • Ionis Pharmaceuticals made up 0.05% of Nikko Asset Management Americas's portfolio in Q2 2026, its #114 holding.
  • Nikko Asset Management Americas first reported a position in Ionis Pharmaceuticals in Q1 2019 and has held it in 30 quarters since.
  • Nikko Asset Management Americas's Ionis Pharmaceuticals position peaked at $25.7M in Q4 2019.
  • 513 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Nikko Asset Management Americas's 13F filing for Q2 2026, filed 13 Aug 2026.